TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32470753

Group type: EXPERIMENTAL
Intervention: Active suicidal intent (wanted to die)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Passive suicidal intent (didn't care about the risks)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Active/passive intent (vs. no intent)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Use of ≥5 substances (vs. 1 substance)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Cocaine or crack use during last overdose
Number of subjects: 274
Study: 36494654

Group type: EXPERIMENTAL
Intervention: Individualized PEEP
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lung-protective ventilation with PEEP of 5 cm H2O
Number of subjects: 106
Study: 32616883

Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 46
Study: 34423370

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study: 32963103

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (72 IU)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (72 IU) with instructed mimicry
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 37137551

Group type: EXPERIMENTAL
Intervention: Exercise with painful injection (hypertonic saline, 5.8%)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exercise with non-painful injection (isotonic saline, 0.9%)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Painful injection (hypertonic saline, 5.8%)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-painful injection (isotonic saline, 0.9%)
Number of subjects: 34
Study: 33676870

Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy
Number of subjects: 2

Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 2
Study: 32998747

Group type: EXPERIMENTAL
Intervention: 1-week (5 fractions) regimen of radiotherapy (26 Gy/5 fractions/1 week)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Standard 3-week (15 fractions) schedule of radiotherapy (40 Gy/15 fractions/3 weeks)
Number of subjects: 2100
Study: 37552627

Group type: EXPERIMENTAL
Intervention: In-person SMART training (video teleconference or face-to-face)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Computer-based SMART training
Number of subjects: 56
Study: 34417343

Group type: EXPERIMENTAL
Intervention: Continuous intravenous lidocaine infusion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ultrasound-guided unilateral, single-injection TAP block
Number of subjects: 120
Study: 32656713

Group type: EXPERIMENTAL
Intervention: Olfactory loss
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sinonasal symptoms
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Taste impairment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Age relation to sinonasal symptoms
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Relation between olfactory loss and sinonasal symptoms
Number of subjects: 100
Study: 36113201

Group type: EXPERIMENTAL
Intervention: PPT-based training (8 sessions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 64
Study: 34648905

Group type: EXPERIMENTAL
Intervention: Coffee beverage A (400 mL/day containing 787 mg of chlorogenic acids)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Coffee beverage B (400 mL/day containing 407 mg of chlorogenic acids)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (not specified, assumed no coffee consumption)
Number of subjects: 74
Study: 32619388

Group type: EXPERIMENTAL
Intervention: Biologics
Number of subjects: 156

Group type: COMPARATOR
Intervention: Non-biologics
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 156
Study: 33712253

Group type: EXPERIMENTAL
Intervention: 1 µg.kg-1 clonidine intravenously
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no clonidine)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 34140087

Group type: EXPERIMENTAL
Intervention: Abdominal binder worn during the daytime for 14 days after surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: No abdominal binder
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 40
Study: 32890444

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB/PDT group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL/PDT group)
Number of subjects: 20
Study: 36181992

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 24
Study: 33725323

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) plus Aspirin (100 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 32891268

Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 128
Study: 35086621

Group type: EXPERIMENTAL
Intervention: 4R (rifampicin for 4 months)
Number of subjects: 1017

Group type: COMPARATOR
Intervention: 9H (isoniazid for 9 months)
Number of subjects: 1017
Study: 34272849

Group type: EXPERIMENTAL
Intervention: lonapegsomatropin 0.24 mg hGH/kg/week
Number of subjects: 161

Group type: COMPARATOR
Intervention: daily somatropin (equivalent weekly dose delivered daily)
Number of subjects: 161
Study: 32561603

Group type: EXPERIMENTAL
Intervention: MSCT monotherapy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MSCT plus recombinant human IFN-γ treatment
Number of subjects: 63
Study: 35242203

Group type: EXPERIMENTAL
Intervention: Dynamic monitoring of lipid metabolism indexes and regulation of blood lipids on top of routine hypoglycemic treatment (Group B)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Routine hypoglycemic treatment (Control Group)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Serum TG level
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Serum TC level
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Serum LDL-C level
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Serum HDL-C level
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Combined detection of lipid metabolism indexes (TC, TG, HDL-C, LDL-C)
Number of subjects: 192
Study: 32246779

Group type: EXPERIMENTAL
Intervention: EAT-10 questionnaire
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: EAT-10 score cutoff point
Number of subjects: 57
Study: 32003816

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (weekly for 4 weeks, every 2 weeks for 4 weeks, and monthly thereafter, provided relapse prevention therapy and buprenorphine)
Number of subjects: 98

Group type: COMPARATOR
Intervention: In-person intervention (weekly for 4 weeks, every 2 weeks for 4 weeks, and monthly thereafter, provided relapse prevention therapy and buprenorphine)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: In-person intervention
Number of subjects: 98
Study: 32753555

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (ET)
Number of subjects: 128
Study: 35660987

Group type: EXPERIMENTAL
Intervention: Dysphagia Standard Assessment (DSA®) test with different volumes and viscosities
Number of subjects: 72
Study: 32981755

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 690
Study: 33934076

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg Q4W
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg Q8W
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120
Study: 32041720

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (Eylea) given via loading dose (three injections) followed by treat and extend protocol over 12 months
Number of subjects: 30
Study: 34014028

Group type: EXPERIMENTAL
Intervention: 2 mg naltrexone
Number of subjects: 67

Group type: COMPARATOR
Intervention: 10 mg amitriptyline
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: naltrexone
Number of subjects: 67

Group type: COMPARATOR
Intervention: amitriptyline
Number of subjects: 67
Study: 32647469

Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Platelet Rich Fibrin (PRF)
Number of subjects: 26
Study: 34654525

Group type: EXPERIMENTAL
Intervention: Weekly participatory art-based activities at the Montreal Museum of Fine Arts over a 3-month period
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (no participation in art-based activities)
Number of subjects: 165
Study: 33835035

Group type: COMPARATOR
Intervention: Revised CDS influenza alert
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three versions of text supporting tobacco cessation alerts (financial, quality, regulatory) with three supporting images
Number of subjects: 0
Study: 33218513

Group type: EXPERIMENTAL
Intervention: Orthotic-garment worn throughout the day with maximal cane-use reduction (Phase B)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Participant-determined follow-up (Phase C)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Cane-walking 'as usual' (Phase A)
Number of subjects: 4
Study: 32998597

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-emotional writing intervention (Control)
Number of subjects: 90
Study: 34146843

Group type: EXPERIMENTAL
Intervention: Integrated person-centred palliative care delivered by multidisciplinary palliative care teams working with general practitioners and community nurses.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 32864921

Group type: EXPERIMENTAL
Intervention: Standard nursing guidelines
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine institutional orientation
Number of subjects: 44
Study: 34896444

Group type: EXPERIMENTAL
Intervention: Tailored educational materials
Number of subjects: 219

Group type: COMPARATOR
Intervention: Existing national screening guidelines
Number of subjects: 219
Study: 33450079

Group type: EXPERIMENTAL
Intervention: ONO-7684 (250 mg daily for 14 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ONO-7684 (1-300 mg single doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ONO-7684 (single and multiple doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ONO-7684 (single doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ONO-7684 (multiple doses)
Number of subjects: 100
Study: 32532346

Group type: EXPERIMENTAL
Intervention: 2-h single-session skills-based pain management class
Number of subjects: 136

Group type: COMPARATOR
Intervention: 2-h health education active control group
Number of subjects: 136
Study: 33618060

Group type: EXPERIMENTAL
Intervention: ROR plus video and text messages (enhanced ROR)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard Reach Out and Read (ROR)
Number of subjects: 160
Study: 33059633

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 3922

Group type: EXPERIMENTAL
Intervention: Patient self‐monitoring group
Number of subjects: 3922

Group type: EXPERIMENTAL
Intervention: Midwife‐assisted RM group
Number of subjects: 3922
Study: 36231362

Group type: EXPERIMENTAL
Intervention: Intuitive eating intervention (5 weeks facilitated by Registered Dietitians)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Waitlist control group (no intervention)
Number of subjects: 14
Study: 34268944

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Pembrolizumab alone
Number of subjects: 44
Study: 34846023

Group type: EXPERIMENTAL
Intervention: DBC treatment with modern rehabilitation equipment
Number of subjects: 196

Group type: COMPARATOR
Intervention: Traditional form of therapeutic exercise
Number of subjects: 196
Study: 36006997

Group type: EXPERIMENTAL
Intervention: Breathing reeducation (BR)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Routine physical therapy (RPT)
Number of subjects: 68
Study: 34250935

Group type: EXPERIMENTAL
Intervention: Dietary AGEs reduction intervention (in addition to standard of care guidelines)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard of care (SOC) guidelines for good glycemic control
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dietary AGEs reduction intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard of care (SOC) guidelines
Number of subjects: 75
Study: 36130917

Group type: EXPERIMENTAL
Intervention: Clinician-supported, web-based intervention (n = 50)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care control (n = 53)
Number of subjects: 103
Study: 34177914

Group type: EXPERIMENTAL
Intervention: AERAS‐402 (3 x 10^10 viral particles)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33107334

Group type: EXPERIMENTAL
Intervention: Robotic sacral colpopexy using autologous fascia lata
Number of subjects: 64

Group type: COMPARATOR
Intervention: Robotic sacral colpopexy using synthetic mesh
Number of subjects: 64
Study: 35969933

Group type: EXPERIMENTAL
Intervention: Patient education bundle intervention
Number of subjects: 16865

Group type: COMPARATOR
Intervention: Control group (pre-intervention)
Number of subjects: 16865
Study: 33752222

Group type: EXPERIMENTAL
Intervention: Strength-dominated exercise program (10 weeks, 3 times per week, 30 minutes per session)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 33685871

Group type: EXPERIMENTAL
Intervention: App-based treatment (URinControl)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 262
Study: 32041657

Group type: EXPERIMENTAL
Intervention: MTX 25 mg (oral or subcutaneous) once weekly plus LEF 20 mg daily
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo instead of LEF daily
Number of subjects: 78
Study: 36103724

Group type: COMPARATOR
Intervention: Simulated altitude at 0 m (sea level, SL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Simulated altitude at 1111 m (MILD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Simulated altitude at 2222 m (MOD)
Number of subjects: 24
Study: 33787632

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for 2 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no IMT)
Number of subjects: 42
Study: 33256863

Group type: EXPERIMENTAL
Intervention: Camels aged 6-10 years
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Herds with 25 or more camels
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Camels from Gabra community
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Overall MERS-CoV IgG seropositivity
Number of subjects: 493
Study: 36249235

Group type: EXPERIMENTAL
Intervention: Short Breathing Technique (SBT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Long Duration Breathing Technique (LBDT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Yogic breathing
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 32004081

Group type: EXPERIMENTAL
Intervention: MAP72 (mean arterial pressure target of 72 mm Hg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: MAP65 (mean arterial pressure target of 65 mm Hg)
Number of subjects: 50
Study: 35780811

Group type: EXPERIMENTAL
Intervention: Medical management with mifepristone and misoprostol
Number of subjects: 1000000

Group type: COMPARATOR
Intervention: Office uterine aspiration
Number of subjects: 1000000
Study: 34043158

Group type: COMPARATOR
Intervention: Transarterial chemoembolization (cTACE) using Lipiodol only (group 1)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization (cTACE) using Lipiodol combined with degradable starch microspheres (DSM) (group 2)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Overall survival for cTACE with Lipiodol plus DSM
Number of subjects: 61

Group type: COMPARATOR
Intervention: Overall survival for cTACE with Lipiodol only
Number of subjects: 61
Study: 32030734

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (n = 142)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard fluid therapy (n = 141)
Number of subjects: 283
Study: 34585675

Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33781134

Group type: EXPERIMENTAL
Intervention: Posterior reconstruction of pubourethralis with Rocco stitch
Number of subjects: 206

Group type: COMPARATOR
Intervention: Rocco stitch (control group)
Number of subjects: 206
Study: 32661605

Group type: EXPERIMENTAL
Intervention: Overweight and obese children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with both overweight and hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral and central SBP, body mass index (BMI), and hemodynamic parameters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral and central SBP and cardiac index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower and highest 24‐h PWV quartile groups
Number of subjects: 0
Study: 32473624

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 0
Study: 35208561

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Therapy (HBOT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no HBOT)
Number of subjects: 71
Study: 32890574

Group type: EXPERIMENTAL
Intervention: Ingestion group (CMF) - at least 10 mL of cow's milk formula daily between 1 and 2 months of age
Number of subjects: 491

Group type: COMPARATOR
Intervention: Avoidance group (no CMF) - avoid cow's milk formula and supplement with soy formula as needed
Number of subjects: 491
Study: 35416566

Group type: COMPARATOR
Intervention: Control arm of the ORBIT-Trial (pre-COVID group, n=44)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control arm of the ORBIT-Trial (during-COVID group, n=47)
Number of subjects: 112
Study: 34968929

Group type: EXPERIMENTAL
Intervention: Portfolio as an assessment tool
Number of subjects: 15
Study: 33438846

Group type: COMPARATOR
Intervention: Custodiol cardioplegia (CC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia (BC)
Number of subjects: 30
Study: 36484665

Group type: EXPERIMENTAL
Intervention: High-translucency zirconia (ZC)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High-translucency zirconia with a partial buccal veneer (ZC-V)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Lithium disilicate glass-ceramic (LDS)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All crown types
Number of subjects: 71
Study: 34514949

Group type: EXPERIMENTAL
Intervention: Computed tomography-guided microwave ablation (MWA)
Number of subjects: 304
Study: 32912308

Group type: EXPERIMENTAL
Intervention: Learning Together whole-school intervention with staff training in restorative practice, a social and emotional learning curriculum, and an external facilitator.
Number of subjects: 0
Study: 35974296

Group type: EXPERIMENTAL
Intervention: New-generation IPL (Eyesis)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Traditional IPL (E-Eye)
Number of subjects: 132
Study: 32102909

Group type: EXPERIMENTAL
Intervention: Low nicotine cigarettes (various nicotine contents)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Very low nicotine content cigarettes with increased tar yield
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study: 33572368

Group type: EXPERIMENTAL
Intervention: DHA plus EPA (2 g/d)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (wheat germ oil)
Number of subjects: 72
Study: 33032655

Group type: EXPERIMENTAL
Intervention: Visual demonstration of successful PCI (printout picture of coronary angiogram before and after PCI)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Common written procedural report on the procedure (Control group)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Visual demonstration of successful PCI
Number of subjects: 144
Study: 33705210

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (registry-derived patients)
Number of subjects: 2008
Study: 34941209

Group type: EXPERIMENTAL
Intervention: Doppler-guided ligation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ligation without ultrasound
Number of subjects: 120
Study: 36152456

Group type: EXPERIMENTAL
Intervention: Experimental condition (reward for accurate performance estimates)
Number of subjects: 193

Group type: COMPARATOR
Intervention: No-incentive control condition
Number of subjects: 193
Study: 32839125

Group type: EXPERIMENTAL
Intervention: Self-paced deliberation (n = 437)
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Forced deliberation (n = 444)
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: All nurses
Number of subjects: 881
Study: 34120755

Group type: EXPERIMENTAL
Intervention: AI‐ECG
Number of subjects: 1996
Study: 32078356

Group type: EXPERIMENTAL
Intervention: Breakfast in the Classroom (BIC) initiative
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Control schools (breakfast in cafeteria before school)
Number of subjects: 1362
Study: 35313978

Group type: EXPERIMENTAL
Intervention: Golimumab 2 mg/kg administered at weeks 0 and 4, then every 8 weeks through week 100 (RA) or week 52 (PsA, AS)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Golimumab (all treated patients)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Concomitant methotrexate
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Concomitant low-dose oral corticosteroids
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Golimumab
Number of subjects: 1279
Study: 33792669

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 32457995

Group type: EXPERIMENTAL
Intervention: Ceftazidime administered by continuous infusion
Number of subjects: 108

Group type: COMPARATOR
Intervention: Ceftazidime administered by intermittent infusion
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ceftazidime in CF patients
Number of subjects: 108

Group type: COMPARATOR
Intervention: Ceftazidime in non-CF patients
Number of subjects: 108
Study: 36038883

Group type: EXPERIMENTAL
Intervention: Preoperative high-intensity smoking cessation intervention starting 4 weeks before surgery
Number of subjects: 251

Group type: COMPARATOR
Intervention: Advice-only group (control group)
Number of subjects: 251